OpGen Inc (OPGN)

NASDAQ
1.860
-0.030(-1.59%)
Pre Market
1.860
0.000(0.00%)
- Real-time Data
  • Volume:
    1,899,155
  • Bid/Ask:
    1.820/1.860
  • Day's Range:
    1.800 - 1.882

OPGN Overview

Prev. Close
1.89
Day's Range
1.8-1.882
Revenue
4.05M
Open
1.85
52 wk Range
1.63-4.34
EPS
-1.43
Volume
1,899,155
Market Cap
72.45M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,716,314
P/E Ratio
-
Beta
-0.71
1-Year Change
-24.7%
Shares Outstanding
38,950,250
Next Earnings Date
Nov 10, 2021
What is your sentiment on OpGen Inc?
or
Market is currently closed. Voting is open during market hours.

OpGen Inc News

OpGen Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellSell
SummaryStrong BuyStrong BuyStrong SellStrong SellStrong Sell

OpGen Inc Company Profile

OpGen Inc Company Profile

Employees
94

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information of products and services for global healthcare settings to guide clinicians with information about infections, improve patient outcomes and decrease the spread of infections caused by multidrug-resistant organisms (MDROs). The Company’s molecular diagnostics and informatics product candidates and services combine its Unyvero and Acuitas molecular diagnostics and Ares Genetics’ database and the Acuitas Lighthouse informatics platform.The molecular diagnostic tests provide microbial identification and antibiotic resistance gene information. The Acuitas Lighthouse informatics systems are cloud-based informatics offerings, which are designed to combine clinical lab test results with patient.

Read More
  • to the moon
    0
    • This is worse than pump and dump. I will in if this will reach at 0.99/share
      0
      • can anyone tell me why this is abl buy
        0
        • Hodling with diamonds.
          0
          • Yeah they want us to sell so when the price is dip those manipulators will buy.😀. So, I would say, let them down the price, don’t buy for now. Just wait, if they want it at the very low price then let it be. Don’t buy and don’t sell either. 💪💪
            0
            • Manipulation by short hedge funds. No worries.
              0
              • gonna 🚀 fir Thursday-Frfiday premarget, and then this will get to high 4's, at least. buyin more.
                0
                • This gonna be a nice Pop if they try n short this. Ima buy more at 2.80! From there POW 🎉🚀
                  0
                  • Buy more, it will go up this week.
                    0
                    • Im wit u
                      0
                  • got in @3,1 Tarvet 12$
                    0
                    • tarGet
                      0
                  • Now it will tripple. Fda approval
                    0
                    • $4 today? then $6 next week?
                      1
                      • sell
                        9
                        • and why ?
                          0
                      • $OPGN looking to make a run to $5 as cash on hand triples from q4 with expected fda clearance this quarter for amr gene panel. Load the boat!!! Check due diligence post on wallstreetbets. A runner that will run like a stealth under the radar!  https://www.reddit.com/r/stocks/comments/lgkvca/opgn_to_the_moon/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
                        1
                        • $20!
                          1
                          • when
                            0
                        • fraud company i lost my half money with their partners Curetis NV they stole our  money , they will do the same OPGN with you one day they will bankrupt too. Last year bankrupt their partners in Europe in Germany . Look the history before to loose your sweet money.!
                          1
                          • To the moon pls 🚀🚀
                            0
                            • Finally some movements ........
                              0
                              • crap stock...
                                0
                                • 🐇
                                  0
                                  • Could it possibly reach 10?
                                    2
                                    • "Analyst's Opinion Consensus Rating OpGen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Price Target Upside/Downside According to analysts' consensus price target of $12.50, OpGen has a potential upside of 465.6% from its current price of $2.21." Marketbeat https://www.marketbeat.com/stocks/NASDAQ/OPGN/
                                      1
                                      • Ball of lint has recieved a consensus rating of STRONG BUY with price target of $257,000
                                        2
                                    • https://www.globenewswire.com/news-release/2020/08/09/2075334/0/en/OpGen-Co-Markets-COVID-19-Antibody-Test-Kit.html
                                      0
                                      • 10 its a start
                                        0
                                        • sas stas Look, I'm in some distress here. I went from 85k to 17k in the past 2 weeks. I'm having some bad days. Thanks for letting me tell you my windfall loss story
                                          1
                                        • what did you buy?
                                          0
                                        • Mick Westsad to hear this i hope u recover
                                          0
                                      • Is there any official news on this ?
                                        0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.